CRVO logo

CRVOCervoMed Inc

$2.25
$0.64
(22.14%)
Today
Closed $2.25
$0.1593
(7.08%)
After Hours
Updated: 07:49 PM EDT
EarningsAug 13
Mkt Cap$26.76M
Vol1.09M
News
all
press releases
Why Did CRVO Stock Crash 22% In Pre-Market Trading Today?
CervoMed announced a $10.5 million private placement financing, with participation from institutional healthcare investors and company insiders.
Stocktwits
News Placeholder
More News
News Placeholder
Pelthos Therapeutics Inc. (PTHS) Reports Q1 Loss, Beats Revenue Estimates
Pelthos Therapeutics Inc. (PTHS) delivered earnings and revenue surprises of +22.75% and +12.03%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates
Caribou Biosciences (CRBU) delivered earnings and revenue surprises of +21.81% and -4.12%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Misses Revenue Estimates
IDEAYA Biosciences (IDYA) delivered earnings and revenue surprises of -3.35% and -35.62%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
CervoMed Inc. (CRVO) Reports Q4 Loss, Lags Revenue Estimates
CERVOMED INC (CRVO) delivered earnings and revenue surprises of -10.93% and -98.06%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?
PHAR heads into Q4 results, with Ruconest and Joenja sales in focus, pipeline updates looming, and investors eyeing clarity on key regulatory setbacks.
Zacks
News Placeholder
CervoMed Inc. (NASDAQ:CRVO) Given Average Rating of "Moderate Buy" by Analysts
Shares of CervoMed Inc. (NASDAQ:CRVO - Get Free Report) have earned an average rating of "Moderate Buy" from the ten research firms that are covering the company, Marketbeat reports. One equities...
MarketBeat
News Placeholder
CervoMed Inc. (NASDAQ:CRVO) Given Average Rating of "Moderate Buy" by Brokerages
CervoMed Inc. (NASDAQ:CRVO - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eleven research firms that are covering the firm, MarketBeat.com reports. Two analysts...
MarketBeat
News Placeholder
CervoMed Inc. (NASDAQ:CRVO) Receives Average Recommendation of "Moderate Buy" from Brokerages
CervoMed Inc. (NASDAQ:CRVO - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eleven analysts that are covering the company, MarketBeat.com reports. Three equities...
MarketBeat
News Placeholder
Matthew Winton Buys 1,500 Shares of CervoMed (NASDAQ:CRVO) Stock
CervoMed Inc. (NASDAQ:CRVO - Get Free Report) insider Matthew Winton purchased 1,500 shares of the company's stock in a transaction dated Tuesday, November 18th. The shares were bought at an average...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.